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Mechanosensing in Naive CD4+ T Cells
Edward Prawira Judokusumo
T cells are key players in adaptive immune response. Originating from the thymus, they
seek and eliminate infected cells in various locations of our body. T cells are not anchorage-
dependent in nature. However, in our body, cells are constantly under physiological stress. It
is not yet known how natural changes in physical environment could affect T cell behaviors.
This thesis focuses to study the role, pathway, and main mechanism of rigidity sensing in T
cells.
Most studies of T cell rigidity sensing have showed that T cell responses are sensitive
to external forces. It is unclear whether T cells could generate forces, translate them to
biochemical signaling, and regulate their function based on the physical sensing. We tested the
idea by developing the use of substrate with varying modulus to analyze the impact of rigidity
to T cell activation. We demonstrated that mouse naive CD4+ T cells were capable of sensing
and transmitting information from substrate modulus, ultimately affecting the regulation of
cytokine secretion, a key indicator of T cell activation. Interestingly, this cytokine secretion
correlated with increasing substrate rigidity. This increased cytokine secretion diminished
when T cells lost the ability to contract in sensing the underlying substrate rigidity. Contrary
to the presumption that T cells are not able to regulate their function based on the forces
applied to the environment, our study provides the first demonstration that substrate rigidity
has a functional impact to naive CD4+ T cell activation.
To understand the translation process from physical to biochemical signaling in T cells,
we determined the signaling pathway that regulated T cell rigidity sensing. We found that T
cell rigidity sensing was associated with the signaling molecules of the T cell receptor (TCR)
complex, the central pathway of T cell response. Analysis of TCR signaling molecules revealed
that T cell rigidity sensing was mediated downstream of the early signaling components in
the TCR complex.
Lastly, we developed a method of combining micron-scale patterning in elastic substrates to
determine whether T cell mechanosensing was mediated from local adhestion sites or globally
throughout the cell. Circular features of primary signal for naive CD4+ T cells were spatially
segregated and patterned on elastic substrates to analyze T cell contractility in generating
forces across the segregated primary signals, leading to sustained TCR triggering. We found
out that T cell contractility failed to generate forces when the primary signals were arranged
in equilateral triangle geometry, leading to loss of TCR triggering. This result shows that T
cell rigidity sensing is mediated globally throughout the whole cell rather than locally from
adhesion sites. Furthermore, the loss of TCR triggering by T cells when sensing the equilateral
triangle geometry in elastic substrates opens up new ideas in characterizing force generation
within the cell.
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Cancer involves abnormal cell growth in the body. This process often results in the formation
of malignant tumors and ultimately causes death. According to the World Cancer Research
Fund International, there were 14.1 million cases worldwide in 2012. By 2035, the total
number is expected to increase by 10 million. Various cancer treatments including surgery,
chemotherapy and radiation-therapy have been shown to control tumor’s growth [Drebin et
al., 1986]. However, these approaches lack customized dose to every cancer patient, often
produce ill-side effects, and are not persistent over time.
Through the discovery of synthetic antibodies by Georges Kohler and Cesar Milstein in
1975, doctors and scientists began exploring cancer treatments utilizing the hosts immune
system to fight cancer. The therapy was called cancer immunotherapy. Therapeutic cancer
vaccines represent the most common form of immunotherapy. They are aimed at boosting
immune reactivity in the tumor-bearing hosts by injecting antibodies and cytokines [Wang et
al., 1995; Bronte et al., 1995; Chen et al., 1996; Overwijk et al., 1999; Palmer et al., 2004].
Therapeutic cancer vaccines had been effective in fighting cancer, preventing tumor regression
in less than 4% of treated patients [Klebanoff et al., 2011]. Moreover, they show low toxicity
and produce fewer negative side effects compared to conventional cancer treatments. However,
the doses given in therapeutic cancer vaccines are still not specific for each cancer patient.
In the early 1980s, researchers at the National Institute of Health pioneered a new approach
CHAPTER 1. INTRODUCTION 2
to cancer immunotherapy called, adoptive cell transfer (ACT) (Fig. 1.1). The main technology
of ACT lies in treating patients with cell populations (mainly T cells) that have been expanded
ex-vivo [Rosenberg and Terry, 1977; Rosenberg et al., 1986]. To utilize ACT, cancer therapists
must complete two steps; the first step is to generate immune cells targeting specific tumor
from the host. The second step is to generate high number of these cells to mediate cancer
regression. To achieve the first step, immune cells are isolated from the host, subsequently
expanded outside the body and injected back into the patient’s body. ACT has several
advantages compared to therapeutic cancer vaccines. Since the cell population used has an
intrinsic receptor to target cancer cells, ACT has more specificity to eliminate cancer. In fact,
ACT is currently the best therapy for metastatic melanoma patients [Denicoff et al., 1987;
Hunder et al., 2008; Restifo et al., 2012a].
Despite its success, current ACT has two major limitations. First, it can only work
for melanoma patients. Second, his/her condition must be capable of handling rigourous
chemotherapy sessions to deplete the immune system prior to ACT. These limitations prompted
the development of genetically engineered T cells to further tune their specificity against tar-
get tumors. This therapy is called adoptive immunotherapy [Morgan et al., 2006; Porter et
al., 2011; Robbins et al., 2011]. Adoptive immunotherapy process is similar to ACT; once the
patient’s T cells are engineered to recognize a specific tumor target, they are injected back to
the patient. There are three approaches to generate genetically engineered T cells, all of which
use retro- or lenti-viral system [Restifo et al., 2012b]. The first one involves isolating T cells
from patients with good response to ACT, encoding their receptor genes using a lentiviral
system, and transfecting it into human T cells. These transfected human T cells will then
express the receptors specific to their target [Palmer et al., 2008].
A second approach to isolate receptors involves the use of a humanized mouse model. In
this system, mice are genetically modified to express human receptor molecules. These mice
are injected with tumors of interest and their T cells subsequently purified. Their receptor
genes are encoded in a lenti-viral system and transduced into human T cells. These human T
cells express receptors against the specific tumors and are injected into the patient [Johnson
et al., 2009]. The third approach is called chimeric antigen receptors (CAR). It involves
modifying variable region of antibodies to encode genes which can detect structures on the
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Figure 1.1: Schematic of adoptive cell transfer [Restifo et al., 2012b].
surfaces of the target cells. The genes are transduced into T cells using the retro-viral system,
and as a consequence, T cells have an antibody-like ability to target specific cells and enable
the cytolytic process [Sadelain et al., 2009; Morgan et al., 2010].
In either adoptive cell transfer or adoptive immunotherapy, the population of T cells is
crucial to the success of the approach. There are two major sub-populations of T cells used
in both therapies; CD8+ and CD4+ T cells. CD stands for cycstosolic domain, a marker that
distinguishes each T cell subset from another. Both CD8+ and CD4+ T cells work together in
orchestrating the body’s immune system, but each subset has a distinct function. In general,
CD8+ T cells eliminate targeted cells using their cytolytic function while CD4+ T cells secrete
cytokines to help the overall function of both T cells. Due to the cytolytic ability, CD8+ T
cells become the first choice in genetically engineered methods, while ACT relies heavily on
CD4+ T cells. To understand how these cells differ in promoting tumor rejection responses,
we need to explore the basic mechanism of their activation.
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1.2 T cells
When our body detects the presence of foreign agents, it triggers two defensive systems, innate
and adaptive immunity. Innate immunity is the first line of defense in response to foreign
agents. It predominantly consists of phagocytic and natural killer cells. This process is not
specific to certain microbes and in most cases infections are cleared without any response from
the host. An infection occurs if antigens pass through innate immunity, create local infection
sites, and transmit the infection throughout the body. At this time, the second line of defense
called adaptive immunity is activated.
Adaptive immunity is usually initiated within a week after antigens pass through the first
barrier. The process is carried out by T and B lymphocytes which can differentiate into
different effector functions to seek and eliminate infected cells in various locations within the
body. Along the process, these cells have the ability to differentiate into memory cells which
provide more rapid and efficient elimination upon re-infection [Murphy et al., 2007].
Originating from the thymus (T), T cells move around tissues, scanning for their specific
antigens. T cells that have not seen their specific antigens are called naive T cells. Two
major subsets of T cells have briefly discussed in the previous section. When CD8+ T cells
encounter their specific antigens presented by major histocompatibility complex (MHC) class
I, they are primed and become cytotoxic T cells capable of lysing infected cells. On the other
hand, priming of CD4+ T cells can lead to differentiation of cell subsets that have distinct
immunological functions.
Priming of CD4+T cells requires two signals (Fig. 1.2); a primary signal, provided by TCR
interaction with peptide MHC (pMHC) on the surface of antigen presenting cells (APC) and
a co-stimulatory signal, provided by CD28 interaction in T cells to CD80/86 in APC. Upon
encountering these two signals, CD4+ T cells initiate their signaling processes which lead
to regulation of cell responses. The initial biochemical signal is started in the TCR/CD3
complex. The TCR/CD3 complex is composed of a CD3 with γ, δ, ε chains and a recognition
site (Fig. 1.3). When the primary signal is initiated, the immunoreceptor tyrosine-based
activation motifs (ITAM) are phosphorylated, leading to downstream cascades of signaling
molecules [Sloan-Lancaster et al., 1998; Bunnell et al., 2002; Wang et al., 2010]. The CD4+
T cell activation process is succesful when they secrete cytokines, called Interleukin-2 (IL-2)
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Figure 1.2: Signals required tp prime CD4+ T cells. TCR must recognize antigenic peptide
presented on MHC Class II (primary signal) and CD28 must bind to CD80 on the APC
surface (co-stimulatory signal).
[Furtado et al., 2002; Antony et al., 2005]. IL-2 is a crucial component of T cell activation
that regulates proliferation and regulation of other T cells. In medical therapy, IL-2 has also
been used to treat patients with melanoma [SA et al., 1994].
Studies of T cell biology are mostly focused on the biochemical components triggered by
interaction between TCR and pMHC surface. [Germain, 1997; Grakoui et al., 1999; Lee et
al., 2002; 2003; Kupfer and Kupfer, 2003]. In 2005, Mossman et al. provided new insights to
T cell signaling [Mossman et al., 2005]. They showed that T cells altered their TCR signaling
when the TCR and pMHC formation were physically disrupted by chrome barriers. This
means that T cells are able to sense the physical changes in their environment and adjust
their signaling accordingly. Since then, studies of T cell biology bifurcated and opened a new
world to explore the role of forces in T cell activation.
1.3 Rigidity sensing
In our body, cells are constantly under physiological stress [Mason et al., 2012]. Scientists
in 1800s have observed that brain morphology and bone remodelling are sensitive to these
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Figure 1.3: T Cell Receptor complex. The complex is composed of CD3 chains and an antigen
recognition site. ITAM are phosphorylated when TCR binds to peptide MHC.
physiological stresses [His, 1874; Wolff, 1892]. The observation sparked interests in scientific
community and led to a field called mechanobiology in the modern world. The main driving
force for mechanobiology has been the curiosity to understand how cells in micro-meter size
could assemble and shape a living organism (humans, animals, etc.) The extent of mechanobi-
ology is wide and eclectic, ranging from the study of cell-cell contact to signaling molecules
inside cells. In this field, we are particularly interested in exploring how T cells could sense
rigidity.
Cell response to rigidity could arise from internal (applied by cells) and external (applied to
cells) factors. Forces generated by cells to their environment are considered internal factors,
while external forces applied to cells are external factors [Dardik et al., 2005]. This work
focuses on internal factors and the mechanism of how cells could change their function with
respect to generated forces to the environment.
The definition of rigidity is often confusing, notably in mechanobiology publications. In
layman’s term, rigidity is a word that defines whether a material is hard/tough or soft.
Mechanobiologists, scientists who study mechanobiology, interchange rigidity with stiffness
and modulus. There is a distinct conceptual difference between stiffness and modulus. Stiff-
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(a) (b)
Figure 1.4: A uniform steel rod fixed on one end (1.4a) and both ends (1.4b). Stiffness is
different on both cases while modulus is the same.
ness is defined as the ability of a material to resist deformation in response to an applied
force. Modulus is the mechanical properties of a material. Consider the following example,
a uniform steel rod clamped on one end versus that clamped on both ends (Fig. 1.4). A
steel rod clamped on one end (1.4a) has a different stiffness compared to that clamped on
both ends (1.4b). However, the modulus on both cases is the same. From this example, it
can be derived that stiffness is dependent on how the steel rod is structured, i.e. boundary
conditions. The material property, modulus, is independent of how the steel rod is structured.
Modulus is an intrinsic property of the material of interest. For the rest of this thesis, rigidity
is defined as modulus rather than stiffness.
1.3.1 Stiffness and modulus
Researchers mainly use hydrogels to explore cell response to stiffness and modulus. Hydrogels
are composed of two components, a base and a curing agent. To control modulus of the
materials, researchers vary the ratio of base to curing agent, cure the hydrogels, and provide
necessary signals for cell culture [Wang et al., 1995; Lo et al., 2000; Kostic and Sheetz, 2006].
To produce substrates of different stiffness, they create an array of micron sized pillars with
different heights with the same ratio of base to curing agent. Controlling the height of the
pillars will directly control the substrate stiffness [Chen et al., 1996; Bashour et al., 2014].
Two most common hydrogels to use are poly-acrylamide (PA) gels and polydimethylsiloxane
(PDMS).
Differentiation of messenchymal stem cells (MSC) provides an interesting case in point in
mechanobiology. This case shows that differentiation of MSC can be harnessed by controlling
modulus or stiffness of the underlying substrates. MSC cultured in low modulus PA gels
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differentiated to neuron like-cell, while higher modulus of PA gels drove differentiation to
bone- and muscle-like cells. MSC cultured in an array of pillars with different stiffness could
also differentiate to either osteogenetic or adipogenetic-like cells. Although the output was
different, the fate of MSC could be modulated using modulus or stiffness.
This particular case proposes the following question; which one is the true modulator of
rigidity? In PA gels, varying modulus causes a change not only in the mechanical properties
but also the chemical properties of the substrate [Trappmann et al., 2012]. This propelled
the analysis of rigidity sensing through PDMS pillars. However, in PDMS, the modulus of
different pillar heights does not change. It is the stiffness that is modulated. Both methods
were valid and supported by experimental evidences. To avoid confusion, it is imperative to
define rigidity at the beginning of a study. This work is not interested to find a true modulator
of rigidity. It focuses instead on a fundamental level in understanding T cell rigidity sensing
by changing the substrate modulus.
1.3.2 Local and global response of cells to rigidity
The mechanism of how cells sense their environment and adjust their function based on
physical cues is not yet fully understood. There are two conceptual explanations on the
rigidity sensing mechanism. The first one is called the local response and the second one
is called the global response. The basis of a local response lies in understanding rigidity
mechanism at the cell-surface adhesion sites. A case in point is in anchorage-dependent cells,
fibroblasts. Suppose that fibroblasts are cultured in two types of elastic substrates, hard and
soft, containing fibronectin. Fibroblasts will create local adhesion sites (integrin-fibronectin
binding) upon contact with the elastic substrates. The local model explains that transmission
of physical forces from hard and soft surfaces to biochemical signalings occurs at the local
adhesion sites [Choquet et al., 1997; Riveline et al., 2001; Galbraith et al., 2002].
The local model states that there is a molecule that can transduce physical to biochem-
ical signals which leads to regulation of cell function [von Wichert et al., 2003; Giannone
and Sheetz, 2006]. This molecule is called mechanosensor. A mechanosensor is sensitive to
tensional forces and phosphorylated when stretched. On hard elastic substrates, tensional
forces applied by fibroblasts are resisted by rigidity of hard elastic substrates, causing a small
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displacement. When this occurs, the mechanosensor that links receptors on hard elastic
substrates to applied tensional forces is stretched and subsequently phosphorylated. Upon
phosphorylation, downstream signaling cascades are started, leading to regulation of cell func-
tion. On soft elastic substrates, tensional forces applied by fibroblasts overwhelm rigidity of
soft elastic substrates, causing large displacement. As an effect, the mechanosensor is not
phosphorylated and does not cause downstream signaling cascades. The local model has
been supported by experimental evidences and a potential mechanosensor has been identified
[Tamada et al., 2004; Geiger, 2006; Sawada et al., 2006].
Unlike the local model which focuses on adhesion sites, the global model focuses on cellular
level response [Ingber, 2005]. The basis of global response is that cells are able to propagate
tensions over long distances [Wang and Suo, 2005; Yeung et al., 2005]. The global model
concept implies that tensional forces sense the physical cues and transmit them through the
whole cell. Tensional forces in cells are conducted through cytoskeletal machinery. This
machinery is composed of molecular motors and their belts that drive cell movement and
spreading. The activation of molecular motors is through a distinct pathway in the cells.
Upon activation of molecular motors, cells could sense the underlying rigidity of the substrates,
transmit that information globally (throughout the whole cell), and regulate their function
based on the feedback. Cell differentiation, death, and growth have been shown to be regulated
by cellular response to its environment [Discher et al., 2005; Engler et al., 2006].
Mechanosensing is a very dynamic process that involves continual communication between
cells and their environment. Although there are two models on rigidity sensing mechanism,
there is no one model that explains everything. It all depends on the type of environment that
the cells sense and how they will translate the physical information to regulate cell function.
1.4 T cell response to physical environments
When our body encounters infection, our lymph nodes are swollen. At that stage, the number
of lymphocytes from adaptive immune response spikes up; scanning our tisssues for infected
cells. It rises a a fundamental question: can T cells sense the physical environment around
them?
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Understanding T cell biology has largely been focused in understanding T cell interaction
with APC. The interface where these two cells meet is termed immunological synapse (IS)
[Grakoui et al., 1999]. In 2005, a study showed that T cells could alter their signaling when
the immune synapse is altered with chrome barriers. This landmark result indicates that
T cells could sense the underlying chrome barriers and adjust their function accordingly
[Mossman et al., 2005]. From this point, studies of probing T cell response to forces were
focused on external forces application by shear stress and optical tweezers [Kim et al., 2009;
Li et al., 2010].
Although T cells could sense external forces, the mechanism on how they propagate forces
to cell function is still unclear. This work takes a different approach in understanding the
mechanism. Rather than focusing on external forces, it explores T cell mechanosensing by
probing internal forces generated by T cells to their environment. Chapter 2 answers whether
T cell activation is sensitive to rigidity. Chapter 3 provides the pathway that regulates T cell
rigidity sensing. Chapter 4 explores the main mode of T cell rigidity sensing.
1.5 Impact and significance
This study will initiate the first move in understanding components involved in T cell rigidity
sensing and show for the first time that T cell activation is sensitive to rigidity. Insights on the
dynamics of signaling molecules will open up new ideas to further probe T cell mechanosensing.
Study on local and global response will provide another way of thinking on how the TCR is
triggered. Finally, the technique presented in chapter 4 can be used as potential physical
cues to harness T cell differentiation property, which can ultimately lead to improvement of
adoptive immunotherapy.





Recent advances in adoptive immunotherapy have shown that T cell specificity can be im-
proved by genetically engineered T cells using lenti-viral system [Restifo et al., 2012c]. How-
ever, this process is usually not cost-effective and very skill-intensive. When adoptive im-
munotherapy was first introduced, it involved ex-vivo expansion of T cells conducted through
physical stimulation with 3 µm beads coated with immobilized antibodies against CD3 and
CD28, providing primary and co-stimulatory signals for T cell activation. We would like to
explore other methods of physical stimulation that can tune T cell function without sacrificing
time, skills, and resources.
A form of physical stimulation that has not been explored in T cells is the study of rigidity.
Rigidity is mostly studied in anchorage-dependent cells, particularly in intergin- and cadherin-
based adhesion. To feel the underlying rigidity, cells must sense and apply tension to the
substrates. An important component in cells to generate tension is the cytoskeletal machinery.
This machinery is composed of molecular motors and their belts, myosin and actin respectively.
The molecular motor in T cells, non-muscle myosin IIA, is involved in assemblying and moving
TCR microclusters to the immune synapse, T cell crawling and spreading [Ilani et al., 2009;
Jacobelli et al., 2009; Yu et al., 2012]. Inhibiting non-muscle myosin IIA will produce defects
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in T cell function. In MSC, non-muscle myosin IIA functions as a modulator for stem cell
differentiation under different substrate modulus.
Since T cells have the machinery in place, can they modulate their activation based on
substrate rigidity? We explored this question using PA gels of different modulus tethered with
activating antibodies against primary and co-stimulatory signals in T cells. We hypothesize
that T cells can adjust their response based on substrate modulus, which ultimately leads
to modulation of IL-2 secretion. This study will provide the basis in understanding T cell
mechanosensing in chapter 3 and 4.
2.2 Materials and methods
2.2.1 PA gels
To test the rigidity sensing hypothesis, a system with two components had to be developed;
substrates of varying rigidity and a linker to cell adhesion molecules. There are two options
to create a system with varying rigidity. The first option involves varying the ratio of base
and crosslinker, then curing them to get the desired rigidity. The other option is to develop
micron-sized pillar structures and modify their height to achieve the desired stiffness. Both
techniques have been used to control cell function as a function of rigidity [Discher et al., 2005;
Kostic and Sheetz, 2006; Engler et al., 2006; OConnor et al., 2012; Bashour et al., 2014].
Since this study focuses on modulus, we used PA gels to probe T cell activation [Wang
and Pelham, 1998; Kandow et al., 2007]. There are four components in making PA gels:
bis-acrylamide (crosslinker), acrylamide, ammonium persulfate, and TEMED. The mixture
of first two components determines the stiffness of PA gels, while the last two components
act as curing agents that initiate polymerization. In this study, acrylamide concentration was
kept at 10% (w/v). Bis-acrylamide concentration varied from of 0.8, 0.4, 0.1, 0.05, 0.02, and
0.01% (w/v) to produce substrates with bulk Young’s modulus of 200, 100, 25, 10, 5, and 2
kPa respectively (Table 2.1).
Once gel mixtures were completed, linkers for cell adhesion proteins were incorporated,
providing a platform for cell attachment. The choice of the appropiate linker is dependent
on the type and size of cell adhesion molecules. For example, a typical linker in PA gel for
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10% acrylamide
% bis-acrylamide 0.01% 0.02% 0.05% 0.1% 0.4% 0.8%
Elastic modulus (kPa) 2 5 10 25 100 200
Table 2.1: Bulk Young’s modulus at 10% acrylamide with varying % bis-acrylamide measured
with atomic force microscopy.
fibroblast study is sulfo-sanpah. It provides a covalent link between PA gels and integrin,
creating adhesive surface for fibroblasts to spread. However, it does not provide a uniform
distribution of adhesion molecules across gels surface, making it non-ideal for T cells. Instead
of fibronectins, we used activating antibodies that bind to primary (anti-CD3) and costimu-
latory (anti-CD28) signals to provide adhesion and activation for T cells. These antibodies
were labelled with biotin and attached to streptavidin conjugated acrylamide on gel surface
and imaged using microscopy. Epifluorescence microscopy revealed a lateral distribution of
antibodies (Fig. 2.1) that was highly uniform.
To compare the surface concentrations of captured anti-CD3 and anti-CD28, gel sur-
faces were imaged by fluorescence microscopy. The surface concentration of antibodies was
estimated using a 20x objective with 1.6 µm depth of field. For a given concentration of
acrylamide-streptavidin, the measured fluorescence was significantly brighter on gels of re-
duced crosslinking, potentially a result of higher porosity and surface accessibility associated
with these substrates. Consequently, the concentration of acrylamide-streptavidin was ad-
justed for each gel composition to normalize the surface density of tethered antibodies (Fig.
2.2a).
Confocal microscopy (Fig. 2.2b) showed that these antibodies were confined to a thin
(3-4 µm) upper layer of the gel, characterized by a sharp increase in fluorescence within the
first micrometers followed by a more gradual decrease with depth into the gel. These overall
profiles were similar across compositions and the peak fluorescence intensity observed across
the profile was similar for each of the different preparations.
In experiments which anti-CD3 and anti-CD28 were presented on different type of sur-
faces, gels were incubated with one of the antibodies at a concentration of 20 µgml , while the
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(a) (b)
Figure 2.1: Lateral distribution of labelled anti-CD3 and anti-CD28 with different linkers.
(2.1a) Streptavidin-acrylamide provides uniform distribution. (2.1b) Sulfo-sanpah provides
patches of antibodies on gel surface. Scale bar: 8 µm.
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Figure 2.2: (2.2a) Distribution of anti-CD3 and anti-CD28 across PA gel compositions. No
significant difference was detected. (2.2b) Depth profile across gel compositions.
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(a) (b) (c)
Figure 2.3: Schematic of IL-2 assay from Miltenyi Biotec kit. (2.3a) Double-headed antibodies
against IL-2 attach to CD45 on cell surface. (2.3b) IL-2 is captured. (2.3c) Fluorescent labeled
antibodies detect captured IL-2.
other was immobilized onto polystyrene beads of 4 µm diameter following the manufacturer’s
instructions. The polystyrene beads were washed four times in 1x phosphate buffered saline
(PBS) to remove azide and tween solution and incubated with anti-CD3/CD28 at a concen-
tration of 20 µgml overnight. Beads were then washed with 1x PBS and incubated for 1 hour
with 4% bovine serum albumin (BSA). In these experiments, cells were allowed to adhere
onto the gels for 30 minutes and then exposed to an excess of beads (3:1 ratio of beads:cells)
carrying the other protein.
2.2.2 IL-2 secretion assay
Naive CD4+ T cells purified from C57BL/6 mice were seeded onto the substrates at 3,400
cells
mm2
in fully suplemented RPMI media and maintained under standard cell culture conditions.
IL-2 secretion was assayed using the Miltenyi Biotec kit (Fig. 2.3). Cells were incubated
with an IL-2 capture reagent immediately prior to seeding. After 1 hour, the media was
exchanged with pre-warmed, fully supplemented RPMI media. After a total of 6 hours cells
were incubated with an allophycocyanin (APC)-conjugated detection antibody against IL-2
(a second component of the Miltenyi Biotec kit).
Cells were then fixed and imaged by fluorescence microscopy. IL-2 intensity was quantified
from low magnification images with 20x objective (1.6 µm depth of field, 400 µm field of view).
Total fluorescence was measured on a cell-by-cell basis. All images from a single experiment
were collected at the same microscopy session. Cell attachment density was measured by
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phase contrast microscopy 6 hours after seeding, unless otherwise stated. For experiments
examining the effect of cell contractility on IL-2 secretion, blebbistatin was added to the
culture media at the 1 hour timepoint to a final concentration of 100 µM.
2.2.3 Statistics
For assays of IL-2 secretion, fluorescence intensity was measured from at least 500 cells for
each condition. The average fluorescence intensity from these cells was used to represent each
condition and experiments were carried out at least three independent times. All data were
analyzed using standard one- and two-way ANOVA techniques in conjunction with Tukey’s
honest significant difference (HSD) multiple comparison approaches.
2.3 Results and discussion
2.3.1 IL-2 correlates with substrate rigidity
Mouse naive CD4+ T cells were seeded onto PA gels presenting a 1:1 mix of anti-CD3 and
anti-CD28 and secretion of IL-2 over a 6-hour period was compared across gels as a functional
measure of activation using a fluorescence-based, surface capture method (Fig. 2.3). IL-2
secretion was lowest on the softest gels, Young’s modulus (E): 10 kPa, and increased with
substrate rigidity (Fig. 2.4a). A small, but not statistically significant decrease was observed
on the 200 kPa vs. 100 kPa gel, possibly reflecting lower T cell accessibility to the antibodies
due to smaller gel pore size. IL-2 secretion was not detectable on surfaces containing either
anti-CD3 or anti-CD28 alone (data not shown), reflecting the need for both signals in T cell
activation.
Cell attachment also correlated to substrate rigidity, with a lower density of cells observed
on the softest surface compared to the three stiffer preparations (Fig. 2.4b). Decreasing
rigidity below 10 kPa did not change cell response, either in IL-2 secretion and cell attachment
(Fig. 2.5). These results show that cell response can be divided into two ranges: for rigidities
above 25 kPa, cells exhibit attachment and an increasing but saturating IL-2 secretion, and
for rigidities belom 25 kPa, cells have low attachment and IL-2 secretion.
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Figure 2.4: Rigidity dependent activation of T cells. (2.4a) 6-hour IL-2 secretion per cell and
(2.4b) cell attachment correlate with Young’s modulus (E). Data are mean ± SD, n = 7, * p
< 0.05, ** p < 0.005
(a) (b)
Figure 2.5: IL-2 secretion per cell and cell attachment response at E < 10 kPa. Closed squares
indicate IL-2 secretion and cell attachment on PA gels of 2, 5, and 10 kPa. Data are mean ±
SD, n = 3.
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(a) (b)
Figure 2.6: Contractility affects IL-2 secretion on 25 kPa surfaces and greater. Data are mean
± SD, n = 3, * p < 0.05
2.3.2 IL-2 secretion requires T cell contractility
As a first attempt to understand the mechanism behind rigidity-dependent activation, cells
were treated with 100 µM blebbistatin, a specific inhibitor of non-muscle myosin IIA. Treat-
ment of blebbistatin in our system abrogated IL-2 secretion by cells cultured on the three
stiffest gels, suggesting a role of contractility in sensing the underlying substrate rigidity (Fig.
2.6a). IL-2 secretion on 10 kPa gel surface remained low compared to that of cells cultured
on the three stiffest surfaces. This suggests that while contractility could play a role in the
three stiffest surfaces, the rigidity-sensing mechanism on 10 kPa surface differs fundamentally
from that of the three stiffest substrates. Cell attachment on 10 kPa surface was not affected
by blebbistatin, suggesting that attachment of cells under these conditions does not require
contractility. One possible reason is that T cells are not anchorage-dependent in physiological
conditions. Rather than using their contractility to attach, the TCR/CD3 and CD28 receptor
binding complex is sufficient to provide attachment.
2.3.3 T Cell mechanosensing is associated with TCR/CD3 complex
To understand T cell mechanosensing at the molecular level, we need to know whether the
mechanosensing is mediated through CD3 or CD28 complex. To test this hypothesis, we
devised trans-stimulation experiments with PA gels. The experiments consisted on immobi-
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Figure 2.7: CD3-mediated mechanosensing. 16 hour IL-2 secretion. Data are mean ± SD, n
= 3, * p < 0.05
lizing one of the two activating antibodies to poly-acrylamide gels and the other to rigid 4
µm diameter. For clarity, trans-stimulation means that activating antibodies will stimulate
different sides of T cell surface. Cis-stimulation means that activating antibodies will stim-
ulate the same side of T cell surface. A longer incubation period (16 hour) was required to
achieve measureable IL-2 secretion. This delayed response could be attributed to the nature
of trans-stimulation or to the smaller surface presented by individual beads compared to gels.
We found that varying rigidity of PA gels presenting anti-CD3 modulated IL-2 secretion
similar to surfaces presenting both anti-CD3 and anti-CD28 (Fig. 2.7). On the other hand,
varying rigidity of PA gels presenting anti-CD28 showed only a statistically insignificant de-
creasing trend in IL-2 secretion with increasing modulus. Suprisingly, we did not detect
IL-2 secretion using a conventional method for T cell activation by tethering anti-CD3 onto
a solid support and anti-CD28 in solution. Soluble anti-CD28 in concentration of 2-20 µgml
did not produce any measureable IL-2 secretion (data not shown). The result suggests that
mechanosensing is associated with CD3 rather than CD28.
2.4 Summary
This chapter shows that mouse naive CD4+ T cells are sensitive to rigidity. They are able to
sense the substrate rigidity and translate that information biochemical signaling, ultimately
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regulating the IL-2 secretion. This is the first demonstration that substrate rigidity has a
functional impact on T cell activation.
The rigidity-sensing mechanism is divided in two zones: above and below 25 kPa. In region
above 25 kPa, T cell requires contractility to regulate IL-2 secretion. However, cell attach-
ment is independent of contractility. This result indicates that cell attachment is mediated
by lamellpodial actin polymeryzation, triggered by encountering primary and co-stimulatory
signals. Once lamellopodial actin has been laid out, T cells the use contractility to sense rigid-
ity and transmit that information trhoughout the cell body. The rigidity-sensing mechanism
on this zone is mediated by TCR/CD3 complex. In region below 25 kPa, the rigidity-sensing
mechanism is fundamentally different than that of in above 25 kPa.
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Chapter 3
TCR/CD3 Signaling in Rigidity
Sensing
3.1 Rationale
The first step of T cell signaling under physiological conditions is the clustering of TCR
to pMHC molecules. These clusters are transported from the cell periphery to the center,
pushing away integrin (LFA-1) rich region to the periphery. This process takes place at early
timepoint, 2-15 minutes [Lee et al., 2002]. The movement of TCR clusters and LFA-1 is
completely reversed at approximately 15-30 minutes, creating a distinct bulls-eye structure in
the IS [Monks et al., 1998; Grakoui et al., 1999; Lee et al., 2002; Kupfer and Kupfer, 2003].
The IS has two distinct features, a central region filled with TCR-pMHC and CD28-CD80
interactions and a peripheral region filled with integrin interaction to intracellular adhesion
molecules-1 (ICAM-1) in APC surface. Having a stable IS is crucial to initiate downstream
signaling of TCR/CD3 pathway [Davis and Dustin, 2004; Dustin, 2008].
The TCR/CD3 pathway is central to the T cell response. It initiates biochemical signaling
pathways, leading to regulation of cell function. Two most important signaling components
for TCR/CD3 pathaway are the Src-family kinase (SFK) and Syk-family kinase. In CD4+
T cells, SFK docks at the co-receptor CD4. Upon engagement of TCR/CD3 to pMHC or to
anti-CD3, SFK phosphorylates ITAM on TCR-ζ chain [Palacios and Weiss, 2004; Stepanek
et al., 2011]. The phosphorylation of ITAM recruits the Syk-family kinase, Zap-70 to TCR-ζ
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chain [Chan et al., 1991; Wang et al., 2010]. SFK then phosphorylates Zap-70, which leads to
T cell activation. This sequence of events is noticed as early as 2 minutes after engagement
of the primary signal, followed by sustained signaling at 30 minutes.
The structure, function, and distribution of SFK and Zap-70 have been studied extensively
since 1990s. There are two SFKs in T cells: Lck and Fyn. The size of Lck and Fyn is similar; 56
and 59 kDa respectively. In theory, the two proteins are spatially segregated in cell membranes.
As stated before, the two main functions of SFK in T cell are to phosphorylate ITAM and
Zap-70.
Zap-70, a 70 kDa ζ-associated protein, is a protein tyrosine kinase that initiates down-
stream signaling pathways in T cells. To be activated, Zap-70 needs to be phosphorylated by
SFK. Zap-70 has several phosphorylation sites. Some of these are known to act as docking sites
for other proteins and others are known to regulate TCR activation. The two most common
Zap-70 phosphorylation sites are Tyr-319 and Tyr-493. Mutation on phosphorylation sites or
preventing Zap-70 to dock at TCR-ζ chain will abrogate T cell activation [Arpaia et al., 1994;
Elder et al., 1994]. Due to its ability to initiate downstream signaling cascades in T cells,
activation of Zap-70 has been used as the marker for T cell activation.
The role of SFK and Zap-70 in T cell rigidity sensing is unknown. Unlike Zap-70 which
is found exlusively in T cells, SFK has a conservative structure that can be found in many
cell types. In the fibroblasts model for rigidity sensing studies, SFK has been shown as a
crucial component in local force sensing. To briefly recapitulate, the local model states that
forces are sensed at local adhesion sites. A mechanosensor that transduces physical signaling
to biochemical activity has a stretchable substrate domain that is sandwiched by Src-homolog
3 (SH3) domain and Src-binding domain (SB). SFK binds to the Src-binding domain. When
cytoskeletal tensions are resisted by rigid surfaces, the substrate domain is stretched and
phosphorylated. SFK helps enhancing recruitment of downstream signaling molecules upon
stretch-dependent phosphorylation of the substrate domain.
The purpose of this chapter is neither to identify a specific mechanosensor to T cells
nor to create a local model of T cell rigidity sensing. Rather, we want to identify whether
early T cell signaling molecules, SFK and Zap-70, are involved in T cell rigidity sensing. We
examine the dynamics of SFK and Zap-70 at early and late timepoints to determine when
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Figure 3.1: Schematic of early TCR signaling before engagement of TCR to pMHC.
rigidity dependent T cell activation is established. We hypothesize that since SFK and Zap-70
phosphorylation takes place upon engagement of the TCR/CD3 complex, rigidity-dependent
T cell activation would be established at a similar timepoint.
3.2 Materials and methods
3.2.1 Surface and Cell Preparation
PA gel surfaces of 10, 25, 100, and 200 kPa were prepared for this study. Streptavidin-
conjugated acryalmide was polymerized in the gel, providing linkers for biotinylated antibodies
against CD3 and CD28. Anti-CD3 and anti-CD28 antibodies were mixed at a ratio of 1:1, at
a total concentration of 30 µgml .
Naive CD4+ T cells purified from C57BL/6 mice were seeded onto prepared substrates at
a concentration of 3,400 cells
mm2
. For experiments to determine the effect of contractility, 100 µM
of blebbistatin was incorporated in the culture media from the beginning of the experiment.
Epifluorescence microscopy was used to measure whole cell intensity of phosphorylated Zap-70
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Figure 3.2: (3.2a) Engagement off TCR to pMHC phosphorylates ITAMs and recruits Zap-70
to TCR-ζ chain. (3.2b) SFK phosphorylates Zap-70, initating downstream signaling cascades
leading to cell function.
and SFK. The fluorescence intensity was captured with 20x objective with 1.6 µm depth of
field.
3.2.2 Statistics
To analyze phosphorylation of SFK, Zap-70, and Pyk2, fluorescence intensity was measured
from at least 500 cells per condition. The average fluorescence intensity from these cells was
used to represent each condition, and experiments were carried out at least three indepen-
dent times. Data were analyzed using standard one- and two-way ANOVA techniques in
conjunction with Tukey’s HSD multiple comparison approaches.
3.2.3 Immunostaining
Cells were fixed with 2% paraformaldehyde, permeabilized with 0.1% Triton-X solution,
washed at least three times in 1x PBS buffer, and labeled with the following phospho-specific
antibodies: pLck (phospho Tyr-393/4, Novus Biologicals), pZap-70 (phospho Tyr-493, Cell
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Signaling), and pPyk2 (phospho Tyr-580, Invitrogen). Samples were then stained with sec-
ondary antibodies and phalloidin using standard techniques.
3.3 Results and discussion
3.3.1 Loss of IL-2 secretion in T cells cultured on soft surfaces is associated
with early TCR signaling
We followed phosphorylation of SFK and Zap-70 in response to T cell mechanosensing at early
timepoint, 2 minutes. Primary antibodies used to stain activated forms of SFK cannot distin-
guish between Lck (Tyr-394) and Fyn (Tyr-420), two major signaling components involved
in T cell signaling. To measure phosphorylated forms of Zap-70, we used phospho-specific
antibodies that detect the phosphorylation site at Tyr-493.
Following 2 minutes after seeding, clusters of pSFK and pZap-70 were detected by phospho-
specific antibodies, indicating early activation of T cells. On the other hand, cells on 10 kPa
were devoid of pSFK and pZap-70 clusters on cell-gel interface, exhibiting only small accu-
mulation around the cell edge (Fig. 3.3). Quantification of whole cell fluorescence intensity
level of these proteins showed a statistically significant decrease of the cluster intensity for
both pSFK and pZap-70 10 kPa gels compared to the other three stiffest surfaces (Fig. 3.4).
Immunostainings and intensity measurements of pSFK and pZap-70 suggest that loss of
IL-2 secretion and cell attachment on the 10 kPa gel are associated with loss of early TCR
signaling molecules (Fig. 2.4a).
3.3.2 Downstream signaling pathways of pSFK and pZap-70 mediates T
cell mechanosensing
We then examined the dynamics of pSFK and pZap-70 at late timepoint, 30 minutes. By
this time, T cells have entered the sustained activation phase. Cellular level of pSFK and
pZap-70 at sustained activation phase produced a similar pattern in comparison to cellular
level at early timepoint (Fig. 3.5). This result suggests that phosphorylation of SFK and
Zap-70 occurs at 2 minutes and is sustained throughout the culture period.
Inhibition of non-muscle myosin IIA with 100 µM of blebbistatin did not affect cellular
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(a) (b)
Figure 3.3: Distribution of pSFK (3.3a) and pZap-70 (3.3b) in T cells cultured in different
PA rigidities at 2 minutes. Images are representative of a minimum of three independent
experiments. Scale bar: 5 µm.
(a) (b)
Figure 3.4: Cellular levels of pSFK (3.4a) and pZap-70 (3.4b) at 2 minutes. Data are mean
± SD, n = 3, * p < 0.05 compared to 200 kPa surface.
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Figure 3.5: Cellular levels of pSFK (3.5a) and pZap-70 (3.5b) at 30 minutes. Data are mean
± SD, n = 3, * p < 0.05 compared to 200 kPa surface.
level of pSFK and pZap-70 at 30 minutes, indicating that phosphorylation of SFK and Zap-70
is independent of T cell contractility (Fig. 3.6). This result shows that T cell mechanosensing
is mediated downstream of SFK and Zap-70 and upstream of T cell contractility.
3.3.3 Pyk2 may contribute to T cell mechanosensing
We next observed the dynamics of Pyk2, a protein tyrosine kinase in T cells. Structurally,
Pyk2 is a homolog of focal adhesion kinase (FAK). FAK is a protein closely associated with
focal adhesions. There are evidences showing that FAK is essential in cellular mechanosensing.
FAK-depleted cells had the most significant effect on stress fibers compared to that of other
depleted actin proteins [Kim et al., 2012]. The binding of FAK to the SH3 domain of Crk-
associated substrate has also been postulated [Tamada et al., 2004; Sawada et al., 2006].
In T cells, distribution of phosphorylated Pyk2 (Tyr-580) had a similar trend of early TCR
signaling molecules. Phospho-specific antibodies detected clusters of phosphorylated Pyk2 on
the cell-substrate interface in cells cultured in the three stiffest gels, while in cells cultured in
10 kPa, clusters of phosphorylated Pyk2 were restricted to the cell perimeter (Fig. 3.7b).
Quantification of the cellular level of pPyk2 revealed a process that was independent of
rigidity (Fig. 3.7a). However, blebbistatin inhibition of pPyk2 revealed a minor statistically
significant decrease across all substrates (Fig. 3.8a). The result suggests that Pyk2 responds
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Figure 3.6: Inhibition of non-muscle myosin IIA does not affect cellular level of pSFK (3.6a)
and pZap-70 (3.6b). Data are mean ± SD, n = 3, * p < 0.05 compared to 200 kPa surface.
to cell contractility and may contribute to T cell mechanosensing.
3.4 Summary
This chapter provides the analysis of pSFK, pZap-70, and pPyk2 as a function of rigidity.
Phosphorylation of SFK and Zap-70 in early timepoint determine their state in sustained
signaling. Clusters of pSFK, pZap-70, and pPyk2 are restricted to the cell edge for cells
cultured in 10 kPa surfaces. Quantification of cellular level of pSFK and pZap-70 reveals a
smaller statistically significant decrease in 10 kPa compared to the cellular level in the three
stiffest surfaces. The loss of IL-2 secretion in 10 kPa is correlated with loss of pSFK and
pZap-70 in early timepoint.
The phosphorylation of SFK and Zap-70 is independet of contractility, suggesting that
binding of TCR/CD3 complex to anti-CD3 on the surface of PA gel is enough to stimulate
phosphorylation in SFK and Zap-70. This result shows that rigidity-dependent activation of
T cells is mediated downstream of SFK and Zap-70. pPyk2 has a similar trend with pSFK and
pZap-70 at sustained T cell activation. Interestingly, blebbistatin inhibition reduces cellular
level of pPyk2 in cells cultured on all PA gels. This result shows that Pyk2, a homolog of
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Figure 3.7: (3.7a) Cellular level of pPyk2 across PA gel rigidities. Data are neab ± SD, n =
3, * p < 0.05 compared to 200 kPa surface. (3.7b) Distribution of pPyk2 in cells cultured
across rigidity. Scale bar: 5 µm.
(a)
(b)
Figure 3.8: Inhibition of phosphorylated Pyk2 with 100 µM of blebbistatin. (3.8a) Cellular
level of pPyk2 under 100 µM of blebbistatin. Data are mean ± SD, n = 3, * p < 0.05
compared to 200 kPa surface. (3.8b) Distribution of pPyk2 in cells cultured across rigidity
under 100 µM of blebbistatin. Scale bar: 5 µm.
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FAK, may contribute to T cell mechanosensing.
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Chapter 4
Local and Global Response of T
Cells
4.1 Rationale
We identified that T cell mechanosensing is associated with TCR/CD3 complex and mediated
downstream of SFK and Zap-70. To gain better insights into the mechanism, we aimed at
exploring whether T cell mechanosensing is a local or global event. There are three compo-
nents that make up local rigidity event. These are the receptor-ligand binding, transduction
process, and signaling cascades that are responsive to mechanical sensing. On the other
hand, cytoskeletal tension that propagates stresses over long distances is a crucial player in
understanding global event.
The first evidence that showed cell responses to forces were local, was provided by a study
in fibroblasts [Choquet et al., 1997]. This study showed that at local adhesion sites, the link
between cytoskeletal tension and integrin was strengthened by extracellular matrix (ECM)
rigidity. The receptor-ligand binding in this case is integrin and fibronectin on the ECM. If the
surface is hard, cytoskeletal machinery that pulls on the receptor-ligand binding is countered
by rigid surfaces, causing small displacement. A mechanosensor that links integrin-fibronectin
binding to cytoskeletal tension is stretched and phosphorylated. The phosphorylation of the
mechanosensor marks a transduction proccess, converting physical stimuli into biochemical
signaling. Subsequently, downstream signaling cascades are initiated as a reponse to this
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event, leading to up-regulation of cellular function. If the surface is soft, cytoskeletal tension
applied by the cells is not countered by the ECM. The mechanosensor is not stretched and
not phosphorylated, which abrogates transduction processes. Downstream signaling cascades
are not initiated, leading to down-regulation of cellular function.
Researchers have identified a mechanosensor that is sensitive to forces in a family of
SFK, called Cas (Crk-associated substrate). A Cas molecule has a stretchable substrate
domain that is sandwiched by Src-homolog 3 (SH3) domain and Src-binding domain. Upon
application of tension, the substrate domain is stretched and phosphorylated by SFK, leading
to recruitment of downstream signaling molecules. Although, the full model of local rigidity
sensing in fibroblasts has not been proven yet, it provides a good platform in understanding
regulation of T cell mechanosensing.
The global response of rigidity sensing is derived from the ability of cytoskeletal filaments
to propagate stresses over long distances [Yeung et al., 2005; Wang and Suo, 2005]. The
process involves other mechanosensory molecules associated with cytoskeletal machinery and it
has been shown to regulate many aspects of cell function, including differentiation, shape, and
motility. One interesting case of global cell response was noted during culture of fibroblasts
in PA gels. Cultured fibroblasts exhibited stress fibers on stiff PA gels, but not on soft PA
gels. As a consequence, fibroblast morphology was more rounded in soft PA gels compared
to that in stiff PA gels. Another well noted example is differentiation of MSC cultured in
varying PA gel modulus. MSC showed a tendency to differentiate to neuron-like cell on soft
surfaces, while they became muscle- and bone-like on rigid surfaces [Discher et al., 2005;
Engler et al., 2006]. What makes this study interesting is that inhibiting cytoskeletal tension
abrogated their sensitivity to differentiation while keeping other cell components intact. The
result shows that cytoskeletal tension is the main regulator of rigidity sensing.
It is very challenging to state which response is the true regulator of mechanosensing. Both
models need cytoskeletal tension to pull and feel the underlying surfaces to regulate cell func-
tion. The fundamental difference lies in the propagation of the force sensing mechanism. The
local model suggests that force propogation is initiated from the local adhesion sites, trans-
duced to biochemical signals, and led to regulation of cellular responses. The global model
suggests that force propagation is felt globally throughout the whole cell with cytoskeletal
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tension, transduced to biochemical signals, and led to cellular responses. We then devised
experiments to probe local and global T cell responses to rigidity.
To study local and global responses in T cells, we developed a micro-patterning technique
in PA gels (Fig. 4.1). The ability to pattern micron-sized features allow us to confine cell
shape and spreading area, causing an integrated cellular response. Local responses in T cell
mechanosensing can be studied by patterning 1 µm diameter anti-CD3 overlapped by anti-
CD28 in PA gels. Signaling components can then be studied on these local adhesion sites,
which could lead to the development of local responses model in T cells. To study global
responses, arrays of 1 µm diameter anti-CD3 pairs separated by a center-to-center distance
are patterned in PA gels. The center-to-center distance ranges from 3-5 µm. Extending
this distance by more than 5 µm will not provide any useful information since the distance
will be greater than the diameter of T cells, 5-6 µm. To make sure that T cells exclusively
attach within a pair of anti-CD3, each feature-pair is separated by 10 µm center-to-center.
These pair-arrays will allow cytoskeletal components to propagate stresses over a distance and
feeback them globally to the whole cell.
Actin polymerization will be our primary output in studying local and global responses
of T cell to rigidity. When TCR/CD3 engagement takes place, actin filaments are recruited
at the site of T cell contact and provide stability for immune synapse [DeBell et al., 1992;
Valitutti et al., 1995; Kumari et al., 2014]. By analyzing actin at these micro-patterns, we
could follow the events from TCR triggering to cytoskeletal tension.
4.2 Materials and methods
4.2.1 PDMS stamp preparation
Different patterns of 1 µm circular features were made in Poly(methyl-methacrylate) layer on
a Silicon wafer using electron beam litography. PDMS was mixed in curing agent and base
with a ratio of 1:10 respectively and poured onto the silicon mold. The PDMS mixture was
baked overnight at 60 degrees C. After curing, PDMS was released from the silicon mold. The
resulting PDMS stamps are 1 µm in height.
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Figure 4.1: Experimental layout in testing local and global response of T cells. Anti-CD3
(red) overlaps with anti-CD28 (black). d = 1 µm, s = 3, 4, 5 µm.
4.2.2 Preparation of patterned PA gels and naive CD4+ T cells
Micro-patterning in PA gels was done in two steps. The first step consisted of patterning
on a clean glass coverslip. The second step is to sandwich the patterned glass coverslip to a
pre-prepared gel solution. To prepare glass patterned with anti-CD3, round glass coverslips
(12 mm in diameter) were cleaned with 7x detergent until solution was clear. These coverslips
were then washed five times in deionized (DI) water to flush remaining detergent residues and
dried with Nitrogen (N2) gun. Once dried, these coverslips were baked overnight in a furnace
with a temperature of 450 degrees C. Then, the PDMS stamps were incubated for 1 hour
in a mix of biotinylated and inert anti-CD3 with streptavidin acrylamide in 2:2:1 v/v ratio,
respectively.
Following glass baking and PDMS incubation process, PDMS stamps were washed ten
times in a series of 1x PBS, 0.05% Tween in 1x PBS, and DI water. Excess solution was
cleared with N2 gun. The stamps were then placed onto clean glass coverslips and an additional
weight of 4.5 gram was placed on top the stamps to ensure good protein transfer. PA gel
solutions were mixed following the protocol described in chapter 2. After mixing PA gel
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solutions, 10 µl of gel solution and 5 µl of streptavidin conjugated acrylamide were placed
onto gluteraldehyde functionalized coverslips. These solutions must be mixed uniformly prior
to sandwiching with patterned glass coverslips. Once sandwiched, PA gels were cured at
room temperature. Patterned PA gels were ready to use after the gel was fully cured. For the
purpose of this study, only 200 kPa gels (0.8% bis-acrylamide, 10% acrylamide) were used to
study local and global responses. Transferring pattern to surfaces softer than 200 kPa would
distort the pattern shape, which could lead to misinterpretation of the study.
To provide co-stimulatory signals in PA gels, patterned PA gels were incubated with 20
µg
ml of biotinylated anti-CD28 antibody. Naive CD4
+ T cells purified from C57BL/6 mice were
seeded on the substrates at 4,420 cells
mm2
in a fully suplemented RPMI media and maintained
under standard cell culture conditions for 30 mintues, unless otherwise stated.
4.2.3 Immunostaining and actin-cluster quantification
Cells were fixed with a 1:1 mixture of 2% parafolmadehyde and PHEM buffer for 10 minutes,
permeabilized with 0.1% Triton-X solution, washed at least three times in 1x PBS buffer, and
labeled with phalloidin using standard techniques.
Actin images were captured with confocal microscopy after staining. Clusters of actin
were quantified by substracting raw data to its median filtered data and correlating it to
anti-CD3 features. Statistics are carried out for at least three independent experiments, with
5-10 cells per experiment. All data were analyzed with one- and two-way ANOVA techniques
in conjunction with Tukey HSD multiple comparison approaches.
4.3 Results and discussion
4.3.1 TCR triggering is sustained on both local and global responses
Following 30 minutes after seeding, phalloidin staining showed actin clusters on anti-CD3
features patterned glass and 200 kPa gels. The circumferential actin ring around the cell
perimeter provided boundary of cell spreading area. Single 1 µm anti-CD3 dots were enough
to stimulate actin polymeryzation (Fig. 4.2), indicating that TCR triggering took place and
was sustained at local adhesion sites. Actin clusters were also observed in pairs of anti-CD3
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Figure 4.2: Phalloidin staining on a single 1µm anti-CD3 at 30 min timepoint. Actin clustering
activity indicates that TCR triggering is sustained. Images are representative of a minimum
of three independent experiments. Scale bar: 2 µm.
dots (Fig. 4.3). The cytoskeletal machinery was able to generate contractions and to sustain
TCR triggering across pairs of anti-CD3 dots. The generated tension across anti-CD3 were
independent of center-to-center distance within a pair of anti-CD3. The result indicates that
TCR triggering occurs and is sustained regardless whether it is initiated by local adhesion
sites or cytoskeletal tension across the cell.
4.3.2 TCR triggering is loss when sensing equilateral triangle geometry
We extended arrays of anti-CD3 features to push the limit of global responses in T cells.
Instead of having pairs of 1 µm anti-CD3 dots separated by 3, 4, 5 µm center-to-center
distance, we designed two fundamental pattern arrays (Fig. 4.4). The first one consisted of
1 µm anti-CD3 features arranged in square arrays. The center-to-center distance within each
1 µm anti-CD3 feature is varied from 3 to 5 µm (Fig 4.4a). These square arrays allowed
T cells to spread not only across a pair of anti-CD3, but also to three and four anti-CD3
features. The second pattern consisted of equilateral triangle arrays where each anti-CD3
feature was separated by the same center-to-center distance within each other (Fig. 4.4b).
Each equilateral triangle feature was separated by 10 µm to prevent crossover signaling.
We found intriguing results from the latest design. In the square array configuration,
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Figure 4.3: Phalloidin staining of T cells on pairs of anti-CD3. TCR triggering is not af-
fected by local separation of anti-CD3 dots. Images are representative of a minimum of three
independent experiments. Scale bar: 2 µm.
(a)
(b)
Figure 4.4: (4.4a) Square arrays of anti-CD3 (red) overlapped by anti-CD28 antibody. (4.4b)
Equilateral triangle arrays of anti-CD3 overlapped by anti-CD28 antibody. In both cases, d
= 1 µm, s = 3, 4, 5 µm.
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phalloidin staining at 30 minutes showed actin clusters when T cells attached to three anti-CD3
features (right triangle configuration) patterned on glass and 200 kPa, indicating sustained
activity of TCR triggering (Fig. 4.5). Increasing the center-to-center distance of anti-CD3
did not abrogate TCR triggering. This result indicates that cytoskeletal tension is able to
transmit forces across this feature and sustains TCR triggering.
In equilateral triangle array configuration, phalloidin staining at 30 minutes did not show
actin clusters around anti-CD3 dots in cells cultured on 200 kPa gels, indicating loss of TCR
triggering activity. The loss of actin clusters on the equilateral triangle in 200 kPa was not
expected. Quantification of actin clusters showed a statistically significant decrease in average
number of actin clusters per cell in the equilateral triangle geometry (Fig. 4.6). At single
anti-CD3 features, T cells were able to sustain TCR triggering locally both on glass and 200
kPa. When the local adhesion site is extended to a pair of anti-CD3 features, cytoskeletal
tension was able to transmit forces within the pair. This process was independent of center-
to-center distance between anti-CD3 features and the generated tension was able to sustain
TCR triggering.
This trend continued when T cells spread in 200 kPa gels under three anti-CD3 features in
square arrays, creaing a right triangle configuration. However, in equilateral triangle geometry,
cytoskeletal components failed to transmit forces across this geometry and TCR triggering was
lost. When T cells spread under four anti-CD3 dots, cytoskeletal tension succeeded to transmit
forces across this geometry, and actin clusters around the anti-CD3 features were restored.
This recovery process could either be due to a concentration dependent stimulation of TCR
triggering or cytoskeletal tension was able to generate enough forces to sustain TCR triggering
across this geometry. This observation indicates that T cells were able to generate cytoskeletal
tension that senses the geometry and transmit that information globally, regulating their TCR
triggering activity.
4.3.3 Cytoskeletal tension supports TCR triggering prior to sustained sig-
naling
We next examined the temporal behavior of actin clusters in equilateral triangle geometry.
Phalloidin staining on glass at different timepoints (10, 20, and 30 minutes) showed actin
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Figure 4.5: Loss of TCR triggering activity when T cells sensed equilateral triangle geometry
versus other triangle configuration. Images are representative of three independent experi-
ments. Scale bar: 2 µm.
clusters on each anti-CD3 feature, indicating cytoskeletal tension was sufficient to sustain TCR
triggering from early to sustained signaling (Fig. 4.7a). On 200 kPa gels, phalloidin staining
showed that actin clusters were observed on anti-CD3 features by 20 minutes, suggesting that
TCR triggering was previously sustained (Fig. 4.7b). This result shows that T cell contraction
is diminished at sustained signaling.
4.4 Summary
This study shows that T cells globally responded in sensing 1 µm anti-CD3 dots arranged in
equilateral triangle geometry in 200 kPa gels. The contraction generated around this geometry
fails to sustain TCR triggering, indicated by the loss of actin clusters around the anti-CD3
adhesion sites. The burst of actin clusters by 20 minutes in equilateral triangle geometry is
consistent with previous observations that showed immunological synapse formation around
this timepoint [Lee et al., 2002]. Yet, when T cells reach their sustained signaling phase, TCR
triggering is not initiated in equilateral triangle geometry. This sequence of events indicates
that global response in T cell rigidity sensing is initiated in three steps; initial engagment,
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Figure 4.6: Quantification of actin clusters in various geomtery configurations in 200 kPa gels.
Actin clustering was significantly loss in equilateral triangle configuration at 30 minutes, n =
3, * p < 0.05
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(a) (b)
Figure 4.7: Temporal observation of actin clusters in glass (4.7a) and gels (4.7b). Scale bar:
2 µm.
sensing phase, and transmission phase.
Initial engagment takes place anywhere between 2-8 minutes. During this process, TCR
is triggered and actin polymerization takes place on adhesion sites. After actin foundation
has been laid out, T cells enter a second phase, the sensing phase. In this period, T cells
engage their contractility via activation of myosin light chain phosphatase. The contractility
will then subsequently sense the geometry and physical environment in order to sustain TCR
triggering. Once sensing is completed, T cells can then transmit the information through the
whole cell and determine whether contractility is sufficient to sustain TCR triggering, leading
to T cell function.
This is the first study that shows that equilateral triangle geometry in elastic substrates
leads to loss of TCR triggering compared to other pattern configurations. This trend was
conserved in 2 µm anti-CD3 dots arranged in the same configuration (data not shown). This
result indicates that the global response of T cell is conserved, independent of anti-CD3
concentration.
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Chapter 5
Conclusions
This thesis provides understanding in the role, pathway, and main mechanism of naive CD4+
T cell rigidity sensing. We showed that substrate rigidity had functional impact on IL-2 se-
cretion by mouse naive CD4+ T cell. The increased cytokine secretion correlated with rigidity
and diminished without T cell contractility. Another study conducted by O’Connor showed
that IL-2 secretion by human CD4+ T cells decreased with increasing rigidity, indicating an
opposite result from mouse naive CD4+ T cells [OConnor et al., 2012]. Although this result
briefly pointed out that there could be a species dependent response of IL-2 secretion, the
system used to measure IL-2 secretion was not similar in both cases. The IL-2 secretion
study on by O’Connor et al. used PDMS with Young’s modulus much larger than that of PA
gels used to study IL-2 secretion by Judokusumo et al. [Judokusumo et al., 2012]. The IL-2
secretion response when human CD4+ T cells are cultured in PA gels with the same rigidity
as that of naive mouse CD4+ T cells is not yet known.
PA gels have been criticized for not providing the ideal platform to study rigidity sensing
due to changes in the chemistry of ligand presentation [Trappmann et al., 2012]. In response
to this new insight, we found that our system used streptavidin-acrylamide which constituted
different chemistry and ligand presentation to that of Trappmann et al. Beside PA gels,
micron-sized PDMS pillars provide a useful platform to characterize generated forces in T
cells [Bashour et al., 2014]. These generated forces were correlated to stiffness rather than
the intrinsic material property of PDMS. Each system used to probe mechanosensing has its
advantages and disadvantages, there exists no system which provides an ideal platform for
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mechanosensing studies.
Our finding that showed T cell mechanosensing was associated to TCR/CD3 rather than
CD28 complex was far from perfect. There is an evidence showing that the trans-stimulation
configuration is mediated through a different pathway than that of the cis-stimulation con-
figuration [Sanchez-Lockhart and Miller, 2006]. However, the interpretation from the trans-
and cis-stimulation experiments was accurate. So far, we only identified Pyk2, a homolog of
FAK, as a possible component in T cell mechanosensing. Other mechanosensory molecules
such as Cas has not been fully analyzed in T cell mechanosensing.
The finding that T cell contractility was not able to sustain TCR triggering in equilateral
triangle configuration patterned in 200 kPa gel was very intriguing. This result shows that
T cell mechanosensing is mediated globally rather than locally from adhesion sites. The
argument that symmetry plays a crucial component in the loss of TCR triggering activity
is not accurate. The square configuration provides symmetry as well, yet T cells are able
to sustain TCR triggerin in this configuration. The loss of TCR triggering was independent
of distance among the anti-CD3 features and concentration of anti-CD3 (data not shown).
This result opens up new thesis and research projects to be explored. One study could track
the forces generated under the equilateral triangle geometry either with PA gels or micron-
size PDMS pillars. Another study could explore the function of actin induced by anti-CD3
features, to show whether the induced actin is a product of cytoskeletal tension or binding of
TCR/CD3 complex to anti-CD3 antibodies.
Finally, the field of T cell mechanosensing has grown rapidly since the study of Mossman
et al., Kim et al., Li et al., and Puech et al. [Mossman et al., 2005; Kim et al., 2009;
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